Profile
Neena Kadaba is currently a Director at Eyevensys SAS since 2020.
Prior to this, she worked as a Partner at Mission Bay Capital Management, Inc. from 2014 to 2015.
Dr. Kadaba completed her undergraduate and graduate degrees from Massachusetts Institute of Technology in 2003 and received her doctorate degree from California Institute of Technology in 2008.
Neena Kadaba active positions
| Companies | Position | Start |
|---|---|---|
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Develops non-viral gene therapy process for the treatment of ocular illnesses | Director/Board Member | 2020-01-07 |
Former positions of Neena Kadaba
| Companies | Position | End |
|---|---|---|
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It participates in early stage capital transactions. | Private Equity Investor | 2015-12-30 |
Training of Neena Kadaba
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It participates in early stage capital transactions. | Finance |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Develops non-viral gene therapy process for the treatment of ocular illnesses | Commercial Services |
- Stock Market
- Insiders
- Neena Kadaba
















